AptaBio Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 16, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	226,702	171,234	201,805	237,483
Market Cap Growth	25.12%	-15.15%	-15.02%	-
Enterprise Value	215,920	146,945	152,862	-
Last Close Price	8120.00	6370.00	9050.00	10650.00
Forward PE	-	78.10	78.10	78.10
PS Ratio	65.89	50.95	623.11	4911.46
PB Ratio	5.08	3.16	3.29	4.54
P/TBV Ratio	5.26	3.16	3.32	4.54
EV/Sales Ratio	62.75	43.72	471.99	-
Debt / Equity Ratio	0.20	0.14	0.23	0.01
Asset Turnover	0.05	0.04	0.00	-
Quick Ratio	1.15	1.67	65.10	16.58
Current Ratio	1.27	1.79	70.27	19.63
Return on Equity (ROE)	-43.23%	-50.84%	-21.21%	-
Return on Assets (ROA)	-13.89%	-15.24%	-14.22%	-
Return on Invested Capital (ROIC)	-17.97%	-18.90%	-16.50%	-
Return on Capital Employed (ROCE)	-34.40%	-35.80%	-18.40%	-17.30%
Earnings Yield	-8.92%	-17.16%	-5.98%	-4.45%
FCF Yield	-6.91%	-7.24%	-7.65%	-3.32%
Buyback Yield / Dilution	-4.22%	-5.58%	-0.05%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.